71. Shared genetic risk factors between cancer and cardiovascular diseasesAleksander Turk, Tanja Kunej, 2022, izvirni znanstveni članek Ključne besede: cancer, cardiovascular disease, risk factor, chemotherapy, comorbidity, genetic variant, interaction
network, cardio-oncology Celotno besedilo (datoteka, 3,26 MB) Gradivo ima več datotek! Več... |
72. Early cost-effectiveness analysis of electrochemotherapy as a prospect treatment modality for skin melanomaEva Pirc, Carlo Federici, Maša Bošnjak, Barbara Perić, Matej Reberšek, Leandro Pecchia, Nebojša Glumac, Maja Čemažar, Marko Snoj, Gregor Serša, Damijan Miklavčič, 2020, izvirni znanstveni članek Ključne besede: skin cancer, melanoma, electrochemotherapy, electroporation, cost-effectiveness Celotno besedilo (datoteka, 1,22 MB) Gradivo ima več datotek! Več... |
73. Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening settingAnja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak, 2021, izvirni znanstveni članek Ključne besede: cervical cancer, human papillomavirus, screening, validation, alinity, cobas Celotno besedilo (datoteka, 410,13 KB) Gradivo ima več datotek! Več... |
|
|
76. Nutritional status and health-related quality of life in men with advanced castrate-resistant prostate cancerLuka Čavka, Maja Pohar Perme, Branko Zakotnik, Nada Rotovnik-Kozjek, Boštjan Šeruga, 2022, izvirni znanstveni članek Ključne besede: prostate cancer, nutritional status, quality of life Celotno besedilo (datoteka, 1,36 MB) Gradivo ima več datotek! Več... |
77. Tumour budding and poorly differentiated clusters in colon cancer – different manifestations of partial epithelial–mesenchymal transitionAna Pavlič, Emanuela Boštjančič, Rajko Kavalar, Bojan Ilijevec, Serena Bonin, Fabrizio Zanconati, Nina Zidar, 2022, izvirni znanstveni članek Ključne besede: colon cancer, colorectal cancer, epitheliall–mesenchymal transition, miRNA, partial epithelial–mesenchymal transition, poorly differentiated clusters, tumour budding Celotno besedilo (datoteka, 35,60 MB) Gradivo ima več datotek! Več... |
78. Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapyAna Mitrović, Janja Završnik, Georgy Mikhaylov, Damijan Knez, Urša Pečar Fonović, Petra Matjan-Štefin, Miha Butinar, Stanislav Gobec, Boris Turk, Janko Kos, 2022, izvirni znanstveni članek Ključne besede: cathepsin X, cathepsin B, inhibitors, cancer, antitumor therapy, invasion Celotno besedilo (datoteka, 8,24 MB) Gradivo ima več datotek! Več... |
79. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcomaŽiva Zajec, Jaka Dernovšek, Martin Distel, Martina Gobec, Tihomir Tomašič, 2023, izvirni znanstveni članek Ključne besede: cancer, Ewing sarcoma, Hsp90, inhibitor, molecular modelling Celotno besedilo (datoteka, 3,11 MB) Gradivo ima več datotek! Več... |
80. New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicityAna Mitrović, Emanuela Senjor, Marko Jukič, Lara Bolčina, Mateja Prunk, Matic Proj, Milica Perišić, Stanislav Gobec, Janko Kos, 2022, izvirni znanstveni članek Ključne besede: cathepsin V, small-molecule inhibitors, antitumor therapy, cancer, cystatin F Celotno besedilo (datoteka, 3,84 MB) Gradivo ima več datotek! Več... |